Publications de recherche

Principales publications des travaux soutenus par FORCE entre 2008 et 2011 :

  1. Annick Muhlethaler-Mottet, Roland Meier, Marjorie Flahaut, Katia Balmas-Bourloud, Katya Nardou, Jean-Marc Joseph and Nicole Gross. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells.Molecular Cancer 2008, 7:55 doi:10.1186/1476-4598-7-55.
  2. Riggi N, Suvà ML, Suvà D, Cironi L, Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V, Stamenkovic I. EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 2008 Apr 1;68(7):2176-85.
  3. Nicole Gross and Roland Meier Chemokines in Neuroectodermal Cancers: The Crucial Growth Signal from the Soil. Seminars in Cancer Biology, In Press, online 28 October 2008.
  4. Roland Meier and Nicole Gross. Chemokines in neuroectodermal tumors: now for something completely different? Seminars in Cancer Biology,  In Press, online 25 October 2008.
  5. Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, Oberlin O, Lefkopoulos D, De Vathaire F. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):908-15.
  6. Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, Manie E, Raquin MA, Bours D, Carpentier S, Barillot E, Grill J, Doz F, Puget S, Janoueix-Lerosey I, Delattre O. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.J Pathol. 2009 May;218(1):86-94.
  7. Combaret V, Hogarty MD, London WB, McGrady P, Iacono I, Brejon S, Swerts K, Noguera R, Gross N, Rousseau R, Puisieux A. Influence of neuroblastoma stage on serum-based detection of MYCN amplification. Pediatr Blood Cancer, 2009, Sep;53(3):329-31.
  8. Gross N, Meier R. Chemokines in neuroectodermal cancers: The crucial growth signal from the soil. Semin. Cancer Biol. 2009 Apr;19(2):103-10. Review.
  9. Meier R, Gross N. Chemokines in neuroectodermal tumors: And now for something  completely different. Semin Cancer Biol. 2009 Apr;19(2):67. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM. .International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.  Br J Cancer. 2009 May 5;100(9):1471-82.
  10. Flahaut M, Meier R, Coulon, A, Auderset K., Niggli F.K., Martinet, D., Beckman, J., Joseph JM., Mühlethaler-Mottet A and Gross N. The Wnt Receptor FZD1 mediates Chemoresistance in Neuroblastoma through Activation of the Wnt/-catenin pathway. Oncogene 2009, Jun 11;28(23):2245-5.
  11. Fattet S, Haberler C, Legoix P, Varlet P, Lellouch-Tubiana A, Lair S, Manie E, Raquin MA, Bours D, Carpentier S, Barillot E, Grill J, Doz F, Puget S, Janoueix-Lerosey I, Delattre O.  Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol. 2009 May;218(1):86-94.
  12. Mühlethaler-Mottet A, Flahaut M, Balmas-Bourloud K, Nardou K, Coulon A, Liberman J, Thome M  and Gross N Individual Caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis, Cell Death and Disease , 2011, In Press.
  13. Aurélie Coulon, Marjorie Flahaut, Annick Mühlethaler-Mottet, Julie Liberman, Katia Balmas-Bourloud, Katya Nardou, Jean-Marc Joseph, Lukas Sommer, Nicole Gross. Heterogeneity and Plasticity of Neuroblastoma Tumour Initiating Cells. Characterization of «Niche»-related phenotypic and functional subsets. Submitted 2011.